Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Chen ST, et al. Among authors: shariff a. J Immunother Cancer. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675. J Immunother Cancer. 2024. PMID: 38599660 Free PMC article.
Endocrinopathies Associated With Immune Checkpoint Inhibitor Use.
Kotwal A, Kennedy R, Kikani N, Thosani S, Goldner W, Shariff A. Kotwal A, et al. Among authors: shariff a. Endocr Pract. 2024 Jun;30(6):584-591. doi: 10.1016/j.eprac.2024.03.023. Epub 2024 Mar 28. Endocr Pract. 2024. PMID: 38554775 Review.
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
Clarke JM, Gu L, Wang XF, Stinchcombe TE, Stevenson MM, Ramalingam S, Shariff A, Garst J, Nixon AB, Antonia SJ, Crawford J, Ready NE. Clarke JM, et al. Among authors: shariff a. JTO Clin Res Rep. 2022 May 17;3(6):100337. doi: 10.1016/j.jtocrr.2022.100337. eCollection 2022 Jun. JTO Clin Res Rep. 2022. PMID: 35719867 Free PMC article.
Novel cancer therapies and their association with diabetes.
Shariff AI, Syed S, Shelby RA, Force J, Clarke JM, D'Alessio D, Corsino L. Shariff AI, et al. J Mol Endocrinol. 2019 Feb 1;62(2):R187-R199. doi: 10.1530/JME-18-0002. J Mol Endocrinol. 2019. PMID: 30532995 Review.
221 results